(25) “Competing Merger Partner Proposal” means any inquiry, proposal or offer for, or indication of interest in, any (a) direct or indirect acquisition, exclusive license or purchase of any business or assets of Merger Partner or any of the Merger Partner Subsidiaries that, individually or in the aggregate, constitutes 20% or more of the assets of the Merger Partner Business, taken as a whole, (b) direct or indirect acquisition or purchase of 20% or more of any class of any Interests or representing 20% or more of the outstanding voting power of Merger Partner, or (c) merger, consolidation, business combination, stock exchange, joint venture, partnership or similar transaction involving any business of Merger Partner or any Merger Partner Subsidiaries that constitutes 20% or more of the assets of the Merger Partner Business, taken as a whole. None of the Transactions shall be a Competing Merger Partner Proposal.
(26) “Competing SpinCo Proposal” means any inquiry, proposal or offer for, or indication of interest in, any (a) direct or indirect acquisition, exclusive license or purchase of any business or assets of the Company or any of its Subsidiaries that, individually or in the aggregate, constitutes 20% or more of the assets of the SpinCo Business, taken as a whole, (b) direct or indirect acquisition or purchase of 20% or more of any class of any Interests or representing 20% or more of the outstanding voting power of SpinCo, (c) merger, consolidation, business combination, stock exchange, joint venture, partnership or similar transaction involving any business of the Company or any of its Subsidiaries that constitutes 20% or more of the assets of the SpinCo Business, taken as a whole. None of the Transactions shall be a Competing SpinCo Proposal.
(27) “Confidentiality Agreement” means that certain Confidentiality Agreement, by and between Merger Partner OpCo and the Company, dated as of June 29, 2023, as amended, restated or supplemented from time to time, including any addendum thereto.
(28) “Consent” means any consent, clearance, expiration or termination of a waiting period, approval, exemption, waiver, authorization, filing, registration or notification.
(29) “Contract” means any binding contract, agreement, understanding, arrangement, loan or credit agreement, note, bond, indenture, lease, warranty, accepted purchase order with outstanding performance obligations at the applicable time of determination, sublicense or license or other instrument, but excluding any Benefit Plan.
(30) “Contributing Subsidiary” has the meaning set forth in the Separation and Distribution Agreement.
(31) “Contribution” has the meaning set forth in the Separation and Distribution Agreement.
(32) “Controlled Group Liability” means any and all liabilities (1) under Title IV of ERISA, (2) under Section 302 of ERISA, (3) under Sections 412 and 4971 of the Code, or (4) as a result of a failure to comply with the continuing coverage requirements of Section 601 et seq. of ERISA and Section 4980B of the Code.
(33) “COVID-19” means SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemics or disease outbreaks.
(34) “COVID-19 Measures” means any quarantine, “shelter in place,” “stay at home,” workforce reduction, social distancing, shut down, closure, sequester, workplace safety or similar Law, directive, guidelines or recommendations promulgated by any industry group or any Governmental Authority, including the Centers for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response to COVID-19, including the CARES Act and Families First Act.
5